Old Web
English
Sign In
Acemap
>
authorDetail
>
Jerome Durand-Labrunie
Jerome Durand-Labrunie
Institut Gustave Roussy
Medicine
Hepatocellular carcinoma
Hafnium oxide
Cancer research
Clinical endpoint
3
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Results from the phase I dose-escalation study of the radiation enhancer NBTXR3 for the treatment of HCC and liver metastases.
2021
Journal of Clinical Oncology
Thierry de Baere
Marc Pracht
Yann Rolland
Jerome Durand-Labrunie
N. Jaksic
Jean-Pierre Bronowicki
Véronique Vendrely
V. Croisé Laurent
Emmanuel Rio
Samuel Le Sourd
Patricia Saïd
P. Gustin
Christophe Perret
Didier Peiffert
Eric Deutsch
Enrique Chajon
Show All
Source
Cite
Save
Citations (0)
Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial
2020
International Journal of Radiation Oncology Biology Physics
Jerome Durand-Labrunie
A.-S. Baumann
Ahmet Ayav
Valérie Laurent
Emmanuel Boleslawski
Stéphane Cattan
Emilie Bogart
Marie-Cécile Le Deley
Valentine Steen
Thomas Lacornerie
Didier Peiffert
Xavier Mirabel
Show All
Source
Cite
Save
Citations (24)
Treatment of hepatocellular carcinoma and liver metastases with hafnium oxide nanoparticles activated by SBRT: A phase I/II trial.
2020
Journal of Clinical Oncology
N. Jaksic
Marc Pracht
Yann Rolland
Thierry de Baere
Jerome Durand-Labrunie
Jean-Pierre Bronowicki
Véronique Vendrely
Antonio Sa Cunha
V. Croisé Laurent
Emmanuel Rio
Samuel Le Sourd
Patricia Saïd
Sebastian Freund
Edwina Baskin-Bey
P. Gustin
C. Perret
Didier Peiffert
Eric Deutsch
Enrique Chajon
Show All
Source
Cite
Save
Citations (1)
1